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ABSTRACT
We originated and characterized melanoma cell lines derived from tumors of two 
feline and two canine veterinary patients. These lines reestablished the morphology, 
physiology and cell heterogeneity of their respective parental tumors. We evaluated 
the cytotoxicity of bleomycin (BLM) alone, or combined with interferon-β (IFN-β) or 
HSVtk/GCV suicide gene (SG) lipofection on these cells. Although the four animals 
presented stage III disease (WHO system), SG treated feline tumors displayed stable 
disease in vivo, while the canine ones exhibited partial response. Their derived cell 
lines reflected this behavior. Feline were significantly more sensitive than canine cells 
to IFN-β gene transfer. BLM improved the antitumor effects of both genes. The higher 
levels of reactive oxygen species (ROS) significantly correlated with membrane and 
DNA damages, emphasizing ROS intervention in apoptotic and necrotic cell death. 
After 3 days of BLM alone or combined with gene treatments, the colony forming 
capacity of two canine and one feline treatments survivor cells almost disappeared. 
Taken together, these results suggest that the treatments eradicated tumor initiating 
cells and support the clinical potential of the tested combinations.
INTRODUCTION
Some types of human cancer are very similar to 
the corresponding disease in companion animals. The 
auspicious results, derived from immunogene therapy 
studies carried out in companion animals, warrant their 
usage in veterinary clinical oncology [1, 2]. Progress made 
with veterinary cancer bearing patients can significantly 
speed up translational research and benefit both veterinary 
and human patients.
Malignant melanoma (MM) is rare in cats while 
is one of the most common tumors in dogs [1-6]. 
Being clinically similar, both diseases are chemo and 
radioresistant and share similar phenotypes [3-6]. Locally 
growing at first, feline and canine MM eventually will 
invade the lymph nodes and spread to other areas of 
the body. The internal organs most commonly affected 
are the lungs, but it can spread to any part of the body 
[3-6]. These extremely aggressive spontaneous tumors, 
frequently resistant to current therapies, urgently need new 
therapeutic strategies.
Intratumor non-viral suicide gene (SG) therapy 
with thymidine kinase from the herpes simplex virus 
(HSVtk), in combination with the pro-drug ganciclovir 
(GCV), has been extensively and successfully used for 
treating canine malignant diseases [1, 2, 5, 6]. On the other 
hand, Interferon-β (IFNβ) has antitumor effects against 
melanoma, and generally is more potent than IFNα [6, 
7]. Even though clinically effective, the treatment with 
recombinant hIFNα/β protein is associated with substantial 
systemic toxicity that worsens the patient’s quality of 
life and often interferes with the therapy completion 
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[8]. However, the exogenously added recombinant IFNβ 
protein (rIFNβ) can be successfully replaced by the 
transfer of the corresponding gene in vitro [7]. Local 
non-viral delivery of the gene encoding this cytokine 
provides a slow release transgenic system limited to a 
small area, avoiding the adverse events associated to the 
injection of high doses of recombinant interferon protein 
while keeping its therapeutic potential [6]. In addition, 
lipoplexes can facilitate the delivery of bleomycin 
(BLM) into melanoma cells via endocytosis [9]. This 
antineoplastic agent enhances the cytotoxic effects of both 
SG and IFNβ gene expression on human melanoma and 
sarcoma cells [10].
Generally, these studies use established tumor cell 
lines that were kept in culture for many generations, 
making them very different from the original tumors. 
Conversely, companion animals’ primary melanoma 
cell lines, could offer alternative promising models for 
optimizing and predicting the in vivo response of their 
respective tumors to therapeutic strategies [11]. Besides, 
few stable feline and canine melanoma cell lines are 
currently available. Thus, we established and characterized 
four melanoma cell lines derived from surgically excised 
canine and feline melanoma tumors. On these lines, we 
explored the therapeutic potential of the combination of 
BLM with IFNβ gene and SG lipofection.
RESULTS
Melanoma cell lines were derived from highly 
malignant in vivo tumors
To evaluate potential in vivo responses of 
individual spontaneous feline and canine melanomas 
to our treatments, we established and characterized 
four melanoma cell lines, two feline (Dc and Rn) and 
two canine (Bsk and Rk). They derived from surgically 
excised feline oral (Dc) and abdominal (Rn) and canine 
oral mucosal melanoma (Bsk and Rk) advanced tumors of 
veterinary patients. 
Dc feline patient was bearing a highly malignant 
gingival mass of 3.1 cm mean diameter expanding to the 
ipsilateral lymph node (mean diameter 2.2 cm).
Rn feline patient: was carrying two large lesions 
(mean diameter: 7.2 cm and 5.9 cm respectively) of an 
abdominal highly advanced melanoma with metastatic 
spread all over the abdomen.
Bsk canine patient: was bearing a recurrent oral 
Table 1: Characteristics of cultured melanoma cells
Cell line Dc Rn Bsk Rk
Origin oral abdominal oral oral
Cell morphology epithelioid fibroblastic fibroblastic fibroblastic
Spheroid morphology loose (multiple) compact loose loose
Lipofection rate (%) [n] 3.01 ± 1.61 [8] 1.80 ± 0.71 [12] 26.54 ± 7.23 [15]** 16.81 ± 6.91 [12]*
Duplication time (h) [n] 18.08 ± 1.90 [3] 19.89 ± 2.49 [4] 28.87 ± 2.36 [4]* 29.93 ± 1.09 [3]*
Proliferation Index (%) [n] 41.18 ± 1.03 [4] 47.35 ± 2.00 [4] 48.07 ± 4.19 [3] 39.12 ± 5.28 [6]
ROS (geometric mean) [n] 21.47 ± 4.02 [4] 15.41 ± 2.00 [4] 36.73 ± 3.50 [4]** 51.26 ± 2.98 [3]***
Cell granularity (mean) [n] 999.85 ± 86.06 [7]*** 1720.73 ± 109.18 [6] 913.07 ± 158.93 [7]** 996.06 ± 55.70 [6]*
Cell size (mean) [n] 2024.80 ± 204.89 [3]* 1564.45 ± 141.43 [3] 1875.11 ± 138.17 [3]* 1941.58 ± 116.77 [3]*
Clonogenic capacity 
(% seeded cells) [n] 9.14 ± 2.35 [7]*** 33.11 ± 1.66 [3] 11.68 ± 1.95 [6]*** 3.90 ± 0.50 [3]***
Colonies in soft agar
(% seeded cells) [n] 13.08 ± 1.17** 22.83 ± 1.86 9.16 ± 1.03*** 5.37 ± 0.53***
Melanosphere forming 
capacity (%) n.d. 11.18 ± 5.53 [3] 6.715 ± 0.12 [2] n.d.
Time course of growth was determined by trypan blue exclusion cell counting and lipofection efficiency was measured as blue X-Gal stained 
cells as described in Materials and methods. Proliferation index (PIx) of untreated cells was determined by evaluating the percentage of 
cells in the S, G2/M and hyperdiploid phases. ROS: Reactive oxygen species. n.d.: not determined. * vs Rn respective value. One symbol: 
p<0.05, two symbols: p<0.01, three symbols: p<0.001.
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Figure 1: Colonies morphology under adherent and non-adherent (in soft agar) conditions and melanosphere 
morphology. Colonies and melanospheres growing under adherent or non adherent conditions, as described in Materials and Methods, 
were photographed using a Nikon eclipse TE2000-S inverted phase contrast microscope.
tumor progressing on the right maxilla of 3.3 cm mean 
diameter spread to the ipsilateral lymph node (mean diameter 
5.7 cm).
Rk canine patient: was bearing a primary melanoma on 
the left maxilla of 4.7 cm mean diameter with an osteolytic 
metastatic spread.
Melanoma cell lines displayed considerable 
heterogeneity
Melanoma cell lines derived from feline and canine 
tumors of our veterinary patients seem to be able to re-
establish the morphologic and physiologic phenotype of 
their respective in vivo tumors. Compatible with the clinical 
diversity of this disease, feline and canine melanoma cells 
displayed high heterogeneity related to the high variability of 
cell populations [5, 6, 12, 13].
Feline cell lines (Dc,Rn) displaying significantly 
shorter duplication times (DT≅18-20 h), were faster growing 
than the canine ones (Bsk,Rk) with DT≅28-30 h. However, 
the four cell lines exhibited similar proliferation index (PIx) 
as the proportion of cells in S, G2/M and hyperdiploid phases 
(Table 1).
In agreement with the highly malignant and invasive 
Rn tumor, Rn derived cell line also displayed a more 
aggressive phenotype by forming respectively 2-, 2- and 
4-fold more colonies in soft agar; and 3-, 3- and 7- fold 
more adherent colonies than Dc, Bsk and Rk. Accordingly, 
Rn cell line displayed the greatest proportion of cells with 
lower basal ROS levels, lower size and higher complexity 
(Table 1). All these characteristics have been associated with 
a pluripotent/stem cell phenotype [14-18].
Feline and canine melanoma cells were able to form 
colonies and melanospheres
The four melanoma cell lines, when seeded at low 
density, were able to grow as colonies, either in suspension 
(soft agar) or under adherent conditions. 
Under non-adherent conditions, the four cell lines 
formed colonies of different morphology when seeded at 
the same concentration. Dc produced the biggest spherical 
colonies, while Rn, Bsk and Rk tended to form small irregular 
aggregates (Fig.1).
On the other hand, the shape of the colonies formed 
under adherent conditions was very different from those in 
soft agar. Dc, Bsk and Rk tended to form spherical aggregates 
of looser structure. Rk ones adopted a smaller and lax 
structure. Consistent with the high heterogeneity of cell 
populations, Rn tended to form both elongated aggregates and 
dense spherical colonies displaying a spreading pattern. After 
reaching a definite size, Rn colonies spontaneously became 
dense spherical masses that easily detached and persisted at 
the supernatant of the well plate (Fig.1).
Moreover, feline Rn and canine Bsk melanoma cells 
were able to form round and compact melanospheres when 
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seeded under non-adherent and serum-free conditions 
(Fig.1).
Specific markers evidenced the invasive and 
proliferative status of feline and canine melanoma 
cells
Consistent with its faster growing, Dc and Rn nuclei 
were highly positive for the specific proliferation marker 
Ki67 (Fig. 2). The expression of this a nuclear antigen, 
indicator of proliferating cells [19], was moderate in Bsk 
and low in Rk.
In addition, Melan A and gp100, two specific 
and sensitive melanoma antigens associated with cell 
proliferation programs [20], were very elevated in Rn cell 
line. Melan A (expressed in pigmented cells) was also high 
in Dc, moderate in Rk and low in Bsk. Gp100 (expressed 
in activated melanocytes) was high in Rk, moderate in Bsk 
and low in Dc.
In agreement with its fibroblastic phenotypes (Table 
1), Rn, Bk and Rk melanoma cell lines, were positive 
for the mesenchymal marker vimentin (Fig. 2). Even 
Dc, displaying a more epithelioid morphology showed 
a vast subpopulation of vimentin expressing cells. It is 
worth to note that, the four vimentin positive cell lines, 
also co-expressed cytokeratin (CK, a keratinocyte specific 
marker), confirming their invasive and metastatic behavior 
[21]. 
On the other hand, S100A9, a member of S100 
family, was high in Rn, moderate in Rk and low in Dc 
and Bsk (Fig. 2). S100A9 (myeloid-related protein 14), 
implicated in the abnormal differentiation of myeloid 
cells in the cancer stroma, contributes to create an 
immunosuppressive microenvironment that inhibits the 
generation of a protective cellular immune response by the 
tumor-bearing host [22]. Furthermore, only Rn expressed 
the lysosome-associated glycoprotein CD68 (data not 
shown).
Beyond depicting their proliferative and invasive 
Figure 2: Detection of melanoma specific antigenic markers by immunocitochemistry. Cells growing for 2 days onto glass 
slides were fixed and stained with specific antibodies against ki67, melan-A, gp100, vimentin, cyitokeratin (Ck) and S100A9 as described 
in Materials and methods and photographed (400X). The number of + symbols represents a semi-quantitative estimation of the relative 
staining of each individual tumor marker among the four cell lines.
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status, the morphologic analysis and the positive staining 
for most of the assayed markers confirmed the previous 
histopathological diagnosis of melanoma.
Bleomycin enhanced the cytotoxic effects of both 
suicide and IFNβ gene lipofection on melanoma 
cells growing as monolayers and spheroids
The development of new combinations of treatment 
strategies could extensively target different cancer cell 
subpopulations overcoming treatment resistance. In a 
previous work, we found that, the in vitro response of 
tumor derived spheroids (sph) correlated with the clinical 
outcome of the suicide gene treatment observed on canine 
melanoma patients in vivo [11]. Here, we explored if both, 
species-specific feline/canine interferon-β (f/cIFNβ) gene 
and herpes simplex thymidine kinase/ganciclovir (HSVtk/
GCV) suicide gene (SG) therapy could be successfully 
combined with bleomycin (BLM) for treating melanoma 
derived cell lines growing as monolayers (mnl) or sph. We 
estimated the BLM effect at 3 μg/ml and SG cytotoxicity 
at the pharmacologically relevant 5 μg/ml ganciclovir 
(GCV) concentration, similar to the intratumor standard 
dose for our feline and canine patients [5-7].
With the exception of SG in Rn growing as sph, 
the tested cell lines were sensitive to both, IFNβ and SG 
lipofection in both spatial configurations (Fig. 3). Canine 
cell lines (Bsk, Rk), with higher lipofection efficiency 
(≅16-26%), were more sensitive to SG system. Conversely, 
feline cell lines (Dc, Rn), presenting very low lipofection 
efficiency (≅2-3%), were more sensitive to IFNβ gene in 
both spatial configurations (Table 1, Fig. 3). Surprisingly, 
Rn cell line with fair lipofection efficiency (≅2%) was 
sensitive, not only to fIFNβ in both spatial configurations, 
but also to SG gene when growing as mnl.
All cell lines were sensitive to BLM alone: Dc and 
Rk (mnl and sph), Bsk (mnl) and Rn (sph). However, 
unspecific lipofection (βgal) enhanced BLM cytotoxicity 
in the four lines: Dc, Bsk and Rk (mnl), and Rn (sph). This 
effect was probably due to lipoplexes-mediated cellular 
uptake [9]. On the other hand, the combination with BLM 
enhanced the individual effects of both, fIFNβ and SG 
gene, in feline lines (Dc and Rn), and the cIFNβ effects in 
canine lines (Bsk, mnl and sph; and Rk, mnl). The highly 
sensitive canine cell lines, showed equal (mnl) or greater 
response (sph) to the combination BLM/SG with respect 
to SG alone (Fig. 3).
Rk showed greater response to both, SG and cIFNβ 
gene, as monolayers than as their respective spheroids and 
Rn did so only in response to SG (Fig. 3). This decreased 
sensitivity of spheroids would be due to the phenomenon 
called multicellular resistance (MCR) that reflects the 
relative intrinsic treatment-resistant phenotype of most 
solid tumors growing in vivo [11].
As observed in Fig. 3b, the microscopic monitoring 
of treated spheroids paralleled the results obtained in the 
bar plots.
In agreement with the high heterogeneity of 
melanoma, the four cell lines were able to grow as 
multicellular spheroids of different morphologies. The 
small size and looser structure of Dc sph, became more 
lax after treatments (SG excepted). Conversely, Rn cells 
appeared intimately associated with each other and closely 
packed. Treatments, specially the combined ones, resulted 
in a significant reduction of spheroids volume, while 
maintained their degree of compactness (Fig. 3b).
On the other hand, Bsk tended to form spherical 
aggregates displaying a spread pattern, while Rk formed 
intermediate cell clusters. In both canine cell lines, cIFNβ 
gene lipofection alone and combined with BLM caused 
a morphological change consistent of multiple small 
aggregates of cells loosely associated with each other. The 
rest of the treatments decreased the spheroid size while 
maintained their morphology.
In vitro suicide gene sensitivity correlated with 
in vivo tumor response of feline and canine 
melanoma patients
Although the four patients presented stage III 
disease (tumor > 4 cm and/or positive nodes), as defined 
by WHO staging system, the variability of responses 
between individual patients to SG treatment, was 
compatible with the clinical diversity of this disease.
During our veterinary clinical study, Bsk and Rk 
patients displayed a partial response to SG [5], while Dc 
presented stable disease during the 5 weekly suicide gene 
treatments [Finocchiaro et al., unpublished data]. On the 
other hand, the enormous and highly invasive Rn tumor 
showed a fast progression in situ before gene therapy, with 
both large lesions doubling their volume in only 3 weeks 
(from 57.6 to 113.3 cm3 and from 47.2 to 86.7 cm3). Tumor 
growth stopped during the 5 weekly treatments with SG, 
becoming a stable disease. There was little change in size 
for the following 10 weeks and after that growth resumed 
[Finocchiaro et al., unpublished data].
Chemo-gene treatments increased the fraction of 
hypodiploid subG0 apoptotic-necrotic cells 
Cells dying by apoptosis, a regulated cell death, 
activate endonucleases that cleave DNA in fragments 
of approximately 180-200bp. Conversely, necrotic cell 
death occurs drastically, leading to plasma membrane 
permeabilization and to a rapid non-specific cleavage of 
DNA. Thus, cells undergoing apoptosis/necrosis (A/N) 
can be readily identified by flow cytometry as cells with 
hypodiploid or subG0 DNA content after propidium iodide 
staining.
The levels of DNA breakup observed in the cells 
treated with βgal lipofection alone were not significantly 
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Figure 3: Effect of bleomycin (BLM) on the sensitivity of melanoma cells monolayers and spheroids to interferon-β 
(IFNβ) gene and suicide gene (SG) system (HSVtk/GCV) as described in Materials and methods. (a,c) The results 
represent means ± s.e.m. of n ≥ 4 (Rn and Bsk), n ≥ 6 (Rk) and n ≥ 8 (Dc) independent experiments. In this case each value was relative to 
the respective control condition: monolayers (mnl) or spheroids (sph). * vs the respective βgal; o BLM vs their respective value without 
BLM; + BLM/genes combined treatments vs their respective ctl+BLM; # sph vs their respective value in mnl. One symbol: p<0.05, two 
symbols: p<0.01, three symbols: p<0.001. (b,d) Images represent individual melanoma spheroids treated as described in the bar plots. 
Spheroids growing in suspension in 96-well plates for 10 days were photographed using an inverted phase contrast microscope (100X).
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different from those observed in unlipofected control cells. 
SG produced a significant increase of cells accumulated 
in the hypodiploid subG0 A/N region in the four cell lines. 
IFNβ gene lipofection did so in Dc and Rk. Interestingly, 
BLM alone or combined with gene treatments, increased 
even more this fraction of cells in the four cell lines (Fig. 
4a).
On the other hand, the four cell lines exhibited an 
inverse correlation between the fraction of hypodiploid 
subG0 A/N cells and cell survival to all the treatments in 
both spatial configurations (Fig. 4b).
The treatments increased the fraction of necrotic 
cells
In contrast to the apoptotic pathway, necrosis has 
obvious implications for the in vivo success of treatments. 
The intracellular content leaking to the extracellular 
space through damaged plasma membrane may induce 
the development of in vivo strong immune response that 
could provide additional antitumor activity. In order to 
quantify this process, we measured propidium Iodide (PI) 
uptake by unfixed necrotic cells with permeable plasma 
membranes.
Three days after IFNβ gene and SG lipofection the 
four cell lines significantly increased the necrotic cell 
death. BLM alone or combined with both genes induced 
a significant additional increase of necrotic cells (Fig. 5a).
On the other hand, the four cell lines exhibited an 
inverse correlation between the fraction of necrotic cells 
and cell survival to all the treatments in both spatial 
configurations (Fig. 5b).
Chemo-gene treatments increased the 
subpopulation of cells with high ROS content
Reactive oxygen species (ROS) play a major role 
as mediators of IFNβ gene cytotoxic effects in human 
and canine melanoma cell lines [7]. Thus, we explored 
a possible link between the cytotoxicity of BLM- gene 
treatments and the increase in intracellular ROS in our 
new established cell lines.
Compared to control cells, we observed that, a 
subpopulation of cells with high intracellular levels of 
ROS was significantly increased by IFNβ gene, in feline 
(Dc and Rn) and canine (Rk) melanoma cells. Conversely, 
Figure 4: Effects of IFNβ gene and SG (HSVtk/GCV) lipofection in the absence or presence of BLM on apoptotic-
necrotic cell death of melanoma cells. (a) The fraction of hypodiploid subG0 apoptotic cells was determined by flow cytometry as 
described in M&M. The results represent means ± s.e.m. of n ≥ 3 independent experiments. * vs the respective β-galactosidase gene (βgal); 
o BLM vs their respective value without BLM; + BLM/genes combined treatments vs their respective ctl+BLM; + BLM/genes combined 
treatments vs their respective βgal+BLM. One symbol: p<0.05, two symbols: p<0.01, three symbols: p<0.001. (b) Correlations between 
hypodiploid subG0 apoptotic cells and cells survival to all treatments in mnl (□) or sph (●) were determined by Pearson test with GraphPad 
Prism program.
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Figure 5: Effects of IFNβ gene and SG (HSVtk/GCV) lipofection in the absence or presence of BLM on necrotic cell 
death of melanoma cells. (a) The fraction of necrotic propidium iodide (PI) stained cells was determined by flow cytometry as described 
in Materials and methods. The results represent means ± s.e.m. of n > 3 independent experiments. * vs the respective β-galactosidase gene 
(βgal); O BLM vs their respective value without BLM; + BLM/genes combined treatments vs their respective ctl+BLM; One symbol: p 
< 0.05, two symbols: p < 0.01, three symbols: p<0.001. (b) Correlations between necrotic propiduim iodide (PI) stained cells and cells 
survival to all treatments in mnl (□) or sph (●) were determined by Pearson test with GraphPad Prism program.
SG induced a significant ROS increase only in canine cell 
lines (Bsk, Rk) (Fig. 6a). It is worth to note the high increase 
of ROS produced by BLM alone or combined with IFNβ 
gene and SG lipofection in the four cell lines. (Fig. 6a). 
The rise in ROS levels correlated with the extent of the 
cytotoxic response. The four cell lines exhibited an inverse 
correlation (p<0.05) between intracellular ROS levels and 
cell survival to the chemo-gene treatments in both spatial 
configurations (Fig. 6b).
On the other hand, we found a direct correlation 
between the subpopulation of cells with high intracellular 
levels of ROS and the fraction of hypodiploid subG0 A/N 
cells (Fig.6c), and with the proportion of necrotic cells with 
PI-positive nuclei (Fig. 6c), in the four cell lines.
The treatments modified the fraction of cycling cells
In a previous paper we demonstrated that, opposing to 
the treatment, there is a repopulation (re-growth) mechanism 
whose strength would be intrinsic of each individual tumor 
[11].
In canine cell lines, SG and combined treatments 
increased the proportion of cells with high proliferation 
index (PIx) (Fig. 7a). Furthermore, both single and combined 
treatments enhanced the proliferative phenotype of Dc cells. 
Conversely, only SG enhanced the proliferative fraction of 
Rn feline cell line.
On the other hand, Dc, Bsk, and Rk cell lines, exhibited 
an inverse correlation between the fraction of cells with high 
PIx and the extent of cell survival to treatments in both spatial 
configurations (Fig. 7b).
Surviving tumor cells displayed a reduced clonogenic 
capacity after treatments
Due to the re-growth resistance effect found after an 
early fast destruction of tumor cells both in vivo and in vitro, 
the long term outcomes of the treatment often differ from 
short term cytotoxic effects. Clonogenic survival studies 
are useful for to evaluate these long term consequences and 
confirmed that the combination was more effective than the 
individual treatments (Fig. 8a,b).
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Figure 6: Effects of SG (HSVtk/GCV) and IFNβ lipofection in the absence or presence of BLM on intracellular reactive 
oxygen species (ROS) production by melanoma cells. Intracellular ROS levels were measured by means of H2DCF-DA probe 
as described in Materials and methods. (a) The results represent means ± s.e.m. of n ≥ 6 (Bsk and Dc), and n ≥ 3 (Rn and Rk) independent 
experiments. * vs their respective βgal; o BLM vs their respective value without BLM; + BLM/genes combined treatments vs their 
respective βgal+BLM. One symbol: p<0.05, two symbols: p<0.01, three symbols: p<0.001. Correlations between the fraction of cells 
with high levels of intracellular ROS and (b) cells survival to all treatments in mnl (□) or sph (●) or (c) SubG0- apoptotic cells (◊) and PI+ 
necrotic cells death (♦) were determined by Pearson test with GraphPad Prism program.
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Despite the great colony-forming capacity (CFC) 
of Rn untreated cells (Table 1), surviving cells to both 
SG and BLM (alone or combined treatments) exhibited a 
significantly decreased CFC.
It is worth to note that the clonogenic capacity of 
Dc, Bsk and Rk surviving cells almost disappeared after 
treatment with BLM alone or combined with genes (Fig. 
8a).
Fig. 8b images represent examples of the clonogenic 
capacity of the surviving cells to treatments described in 
the bars plots. Dc, Bsk and Rk cell lines formed growing 
colonies that were visible in plain sight 10-12 days (Dc 
and Bsk) or about 20 days (Rk) after seeding. Rn colonies 
were not able to reach the same size of the rest at any time, 
as they spontaneously became dense spherical colonies 
that easily detached and persisted at the supernatant of the 
well plate. 
On the other hand, there was a direct correlation 
between the fraction of surviving cells after any treatment 
and their CFC in Dc, Bsk and Rk cell lines (Fig. 8c). The 
higher CFC of Rn cells did not correlate with the extent of 
the cytotoxic responses.
DISCUSSION
Tumors are formed from distinct cell populations. 
This heterogeneity of tumor structure leads to the 
occurrence of sensitivity and resistance to applied 
treatment. One of the critical issues in designing 
efficient therapies is to understand the composition of 
heterogeneous melanoma tumors to target treatment 
resistant cell subpopulations. Here, we established and 
characterized two feline (Dc and Rn) and two canine 
(Bsk and Rk) melanoma cell lines from veterinary 
patients. These cell lines, arose from highly proliferative 
(Rn>Bsk>Dc>Rk) and highly invasive (Rn>Bsk>Dc>Rk) 
advanced tumors. Although the four patients presented 
stage III disease (tumor > 4 cm and/or positive nodes), 
as defined by WHO staging system, feline in vivo tumors 
(Dc, Rn) displayed stable disease (reduction or increase 
Figure 7: Effects of SG (HSVtk/GCV) and IFNβ lipofection in the absence or presence of BLM on the proliferation 
index (PIx) of melanoma cells. (a) Cells growing for 3 days as monolayers were suspended, treated and subjected to flow cytometry 
analysis as described in Materials and methods. Proliferation index (PIx) was determined by evaluating the percentage of cells in the S, 
G2/M and hyperdiploid phases. The results represent means ± s.e.m. of n ≥ 3 independent experiments. * vs their respective ctl; o BLM vs 
their respective value without BLM; + BLM/genes combined treatments vs their respective ctl+BLM. (b) Correlations between PIx and 
survival cells to all treatments in mnl (□) or sph (●) cells were determined by Pearson test with GraphPad Prism program. One symbol: 
p<0.05, two symbols: p<0.01, three symbols: p<0.001.
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in tumor size <50%, data not shown), while canine ones 
(Bsk, Rk) exhibited partial response (reduction of tumor 
size > 50%) to SG treatment [5]. This behavior was 
reflected by their derived melanoma cell lines confirming 
the behavioral similarity between in vivo tumors and their 
in vitro models (Fig. 3).
Even though it was reported that the aggressiveness 
of human melanoma is promoted by aneuploidy-driven 
gene expression deregulation [23], ploidy analysis of 
the four cell lines tested in this work evidenced that they 
are euploid (2n, data not shown). On the other hand in 
a veterinary setting, survival times in dogs and cats with 
melanocytic tumors, was not correlated with modifications 
of DNA content or changes in nuclear morphometry of 
tumor cells [24]. Therefore the basis for the correlations 
between in vivo and in vitro tumor cells behavior should 
be located elsewhere.
Feline cell lines (Dc, Rn), were more sensitive to 
IFNβ gene in both spatial configurations. BLM improved 
the antitumor effects of both genes, suggesting a useful 
interaction between them involving powerful cell death 
mediators. Reactive oxygen species (ROS), triggered by 
treatments, would be among the main molecules involved 
in the process [7]. These data, together with the high 
number of cells with DNA fragmentation and plasma 
membrane disruption, strongly emphasize the role of 
ROS as mediators of cell death mostly through apoptotic 
and necrotic events (Figs. 3-6). Probably BLM, that 
also increases pro-oxidant species, can complement the 
antitumor efficacy of the SG and IFNβ gene and clearly 
causes potentiated effects.
According to the invasive behavior of their 
respective tumors, the four cell lines were positive 
for the mesenchymal marker vimentin (Fig. 2). These 
Figure 8: Clonogenic forming capacity of the surviving melanoma cells to SG (HSVtk/GCV) and IFNβ lipofection in 
the absence or presence of BLM relative to the number of seeding cells, as described in Materials and methods. (a) The 
results represent means ± s.e.m. of n ≥ 3 independent experiments. * vs their respective βgal; o BLM vs their respective value without BLM; 
+ BLM/genes combined treatments vs their respective βgal+BLM. One symbol: p<0.05, two symbols: p<0.01, three symbols: p<0.001. (b) 
Images of a representative experiment. c) Correlations between surviving cells in mnl (□) or sph (●) to all treatments and its clonogenic 
forming capacity as determined by Pearson test with GraphPad Prism program.
Oncoscience210www.impactjournals.com/oncoscience
data suggest that, at the time of tumor resection, a vast 
subgroup of tumor cells of the total population, had 
already suffered the epithelial to mesenchymal transition 
(EMT), increasing their metastatic potential. However, to 
colonize the metastatic site, cells may reverse in part the 
EMT by re-expressing basal-like phenotype-associated 
proteins as cytokeratin (CK) [25]. These vimentin-positive 
cells also co-expressed CK, confirming their invasive and 
metastatic behavior [21]. 
As suggested by Ki67, Melan A and gp100 
melanoma antigen expression (Fig. 2), the four cell lines 
exhibited a proliferative behavior [19]. Bsk, Dc and Rk 
lines responded to our single and combined treatments by 
enhancing the fraction of cells actively proliferating (with 
high PIx, Fig. 7) and with elevated levels of intracellular 
ROS (Fig. 6). It was stated that cells with high intracellular 
ROS levels (Fig. 6) are actively proliferating and more 
sensitive to therapy and differentiation [14]. Besides, 
higher ROS state induces proliferation and differentiation 
of tumor initiating cells (TICs) [14-16]. Conversely, low 
ROS phenotype is a common property of TICs, required 
for the maintenance of their self-renewal capacity, 
quiescent state, high tumorigenicity and therapy resistance 
[14-16].
It is remarkable that Rn cell line, that exhibited 
the lowest levels of ROS, was also enriched with a 
high proportion of cells with both, small size and high 
complexity (Table 1). All these parameters have been 
associated to TICs [14-18]. This cell line, sensitive 
to single and combined treatments (Fig. 3-5), only 
displayed a further increase in the proportion of cells with 
high basal proliferation index (PIx) in response to SG 
treatment (Fig. 7). These data indicate that even within 
highly proliferative melanoma cells, a subpopulation 
resides in a slow-cycling state. These slow-cycling 
cells, characteristics of melanoma TICs, are essential 
for continuous tumor growth [25-29]. According to 
the massive and highly invasive Rn tumor, long term 
repopulation by cell re-growth prevail over an early fast 
destruction by treatments of Rn melanoma cells both in 
vivo and in vitro (Fig. 3). The high Ki67 staining (Fig. 
2), the spheroids multicellular resistance to SG (Fig. 3), 
the significant increase of apoptotic and necrotic death 
in response to treatments (Fig. 4, 5) and the highest 
clonogenic forming capacity (Fig. 8) of Rn surviving cells 
support this hypothesis. Clonogenic survival studies are 
useful for to evaluate long-term outcomes of treatments 
that often differ from short-term cytotoxic effects. When 
surviving Rn cells (derived from a highly aggressive and 
metastatic advanced tumor) were seeded in vitro at low 
density, generated 2-, 2- and 4-fold more colonies in soft 
agar and 3-, 3- and 7-fold more adherent colonies than the 
other three cell lines (Table 1 and Fig. 8). In addition, Rn 
cells showed only a small decrease of CFC of surviving 
cells to SG and BLM (alone or combined with genes) (Fig. 
8).
All these data suggest that tumor initiation was 
not necessarily restricted to a minor population of Rn 
melanoma cells. This cell line may be enriched in both, 
treatments-sensitive cells and TICs. Thus, treatments only 
affect a small fraction of Rn TICs, by promoting self-
renewal or proliferation. Conversely, the higher fraction of 
this particular set remained quiescent, and then, protected 
from a harsh environment that induce its exhaustion [25-
29]. Possibly, in the other three cell lines the constant 
cycling imposed by BLM and the sustained expression 
of IFNβ and SG (Fig. 6), leads to TICs exhaustion [26, 
27]. This was in fact observed in Fig. 8, where the CFC 
of surviving cells almost disappeared after treatment 
with BLM alone or combined with genes. The high 
correlation between the fraction of Dc, Bsk and Rk cells 
surviving to treatments with their CFC (Fig. 8) suggested 
that, our chemo-gene treatments, reduced the melanoma 
TICs compartment in the three lines by promoting 
long-term TICs self-renewal, repopulating activity and 
differentiation.
In our spontaneous canine melanoma clinical trials 
[5], repeated in vivo intra tumor administrations of lipid-
complexed SG plus GCV yielded 62% of in vivo objective 
responses with 30% complete responses. Since TICs are 
responsible of tumor recurrence and metastatic disease 
[28], the high proportion of tumor complete responses 
and metastasis-free patients suggests that our SG therapy 
was able to eliminate TICs in vivo [5]. In addition, our 
surgery adjuvant veterinary clinical trials combination of 
a plasmid DNA vaccine with local SG [5] and SG plus 
cIFNβ [6] delayed or prevented post-surgical recurrence 
and distant metastasis while significantly improved 
disease-free and overall survival of our canine patients. 
Other combination of BLM (as electrochemotherapy) with 
a cytokine gene (IL-12) electrotransfer was successfully 
tested in veterinary patients [30].
The effective clinical outcome of our veterinary 
clinical trials suggest that in vivo continuous and sustained 
local expression of SG and cIFNβ gene, reduce TICs [5-
7], and that such behavior was reflected by their derived 
melanoma cell lines [11]. In addition, the results presented 
here suggest that BLM improves the antitumor effects of 
both genes in both spatial configurations, and produces 
a moderate (Rn) or dramatic reduction (Dc, Bsk, Rk) in 
the CFC of surviving cells in the four melanoma cell 
lines (Fig. 8a). The previously published clinical data [5, 
6] together with the in vitro data presented here, suggest 
that the combination of BLM plus gene treatments could 
eradicate TICs in vivo and strongly supporting the clinic 




Cats and dogs with a confirmed histopathological 
diagnostic of melanoma were recruited for a study as it 
was reported [5, 6]. Their owners were notified about 
the experimental nature of the treatment, and all of them 
granted written informed consent for treatment [5, 6]. 
These tumors were staged by a veterinary oncologist 
according to the WHO staging system of stage III (tumor 
> 4 cm and/or positive lymph nodes). These spontaneous 
melanoma veterinary patients received twice a week 
during 5 weeks, intra- and peri- tumor injection at multiple 
sites of lipid-complexed plasmid DNA encoding HSVtk (1 
to 4 mg DNA co-delivered with 5-20 mg GCV according 
the tumor size).
Establishment of cell cultures from feline and 
canine melanoma tumors
Primary cell lines derived from surgically excised 
feline oral (Dc) and abdominal mucosal melanoma (Rn) 
and canine oral (Bsk and Rk) melanomas were obtained 
by mechanical disruption of tumor fragments in culture 
medium [7, 9]. Periodically tested for mycoplasma 
absence, cells were cultured as monolayers and 
multicellular spheroids as described [7, 9].
For doubling time estimation using GraphPad 
Prism 6 software (GraphPad Software Inc.), cells were 
trypsinized and 5x104 cells were plated in duplicate in 
6-well plates and cultured in normal conditions. After 
trypan blue staining, cells were daily counted in a 
Neubauer chamber.
Immunocytochemistry
Cells attached onto a glass slide were cultured 
for 48 h in the above described conditions. Cells were 
then washed, fixed with ethanol, dried, re-hydrated 
and incubated separately with the following specific 
antihuman monoclonal antibodies as described by the 
manufacturers: (i) from BioGenex: melan A (clone A103), 
S-100A9 (clone 15E2E2), GP100 (clone HMB45); (ii) 
from Dako: cytokeratin (clones AE1/AE3), vimentin, 
CD68 and Ki67. After washing, cells were incubated 2 h 
at room temperature, with Multi-Link immunoglobulins 
(BioGenex) followed by streptavidin/peroxidase conjugate 
and developed with 3,3’-diaminobenzidine [11].
Plasmids and transfection efficiency
Plasmids psCMVβgal (6.8 Kb) [11], psCMVtk 
(4.5 Kb) [11], psCMVcIFNβ (3.9 Kb) [7] and 
psCMVfIFNβ (3.9 Kb) carry respectively Escherichia 
coli β-galactosidase gene (3.5 Kb), herpes simplex 
thymidine kinase (1.2 Kb) and canine or feline IFNβ 
(0.6 Kb) in the polylinker site of psCMV (3.3 Kb), 
downstream of the CMV promoter and upstream of 
poly A sequences. The plasmids (bearing the kanamycin 
resistance gene for selection in Escherichia coli) were 
amplified, chromatographically purified and quality 
assessed as described [11]. Plasmid DNA for injection 
was resuspended to a final concentration of 2.0 mg/ml in 
sterile PBS.
Liposome preparation and in vitro lipofection
DC-Chol (3β[N-(N’,N’-dimethylaminoethane)-
carbamoyl cholesterol) was kindly supplied by BioSidus. 
DMRIE (1,2-dimyristyl oxypropyl-3-dimethyl-
hydroxyethylammonium bromide) was kindly synthesized 
and provided by Dr. Eduardo M. Rustoy. DOPE 
(1,2-dioleoyl-sn-glycero-3-phosphatidyl ethanolamine) 
was purchased from Sigma. Liposomes were prepared at 
lipid/co-lipid molar ratios of 3:2 (DCChol:DOPE) or 1:1 
(DMRIE:DOPE) by sonication as described [11]. Optimal 
lipid mixtures were determined for every cell line.
Cells, seeded onto 12-well plates at a density of 
3-5x104 cells/cm2 were allowed to adhere overnight. 
Monolayers were exposed to lipoplexes (0.5 μg plasmid 
DNA/cm2 and 1 μl liposome/cm2) from 3 to 5 h in a serum-
free medium. Then the lipofection medium was replaced 
with fresh complete medium. The feline and canine cells 
were lipofected with psCMV-fIFNβ and psCMV-cIFNβ 
respectively.
Lipofection rates were checked 24 h after 
lipofection by β-galactosidase staining with 5-bromo-4-
chloro-3-indolyl β-D-galactopyranoside (X-GAL, Sigma) 
and further counting with an inverted phase contrast 
microscope [11].
Sensitivity to bleomycin, suicide gene and IFNβ 
gene assays
Twenty-four hours after lipofection, with suicide 
gene (SG, HSVtk/GCV), feline/canine interferon-β 
(fIFNβ, cIFNβ) or βgal alone or co-delivered with 3 
μg/ml bleomycin (Gador), cells were seeded on regular 
plates as monolayer (3.5 - 7.0 x 104 cells/ml) or on top 
of 1.5% solidified agar to form spheroids (1.0 x 105 cells/
ml) and incubated with medium containing 5 µg/ml 
ganciclovir (Richet). After 5 days in monolayers or 12 
days in spheroids, cell viability was quantified with acid 
phosphatase assay (APH) as described [7, 9].
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Flow cytometry cell cycle analysis and 
quantification of DNA fragmentation
Three days after lipofection, with SG, IFNβ, or βgal 
alone or co-delivered with BLM, cells were trypsinized, 
fixed in 70% (v/v) ethanol at -20°C for 1 h, treated with 
RNase, stained with 10 μg/ml propidium iodide (PI, 
Sigma) for 30 min, and subjected to single-channel flow 
cytometry on a Becton Dickinson FACScan (Franklin 
Lakes), with analysis of data performed using the 
Cylchred software (Cardiff University). Cells displaying 
a hypodipoid content of DNA indicative of DNA 
fragmentation were scored as apoptotic-necrotic.
Quantification of necrotic cells
Three days after lipofection, with SG, IFNβ, or βgal 
alone or co-delivered with BLM, cells were harvested, 
freshly stained (without fixation) with PI solution (5 µg/
ml) for 5 min, and then analyzed by flow cytometry as 
described above. PI enters the cells only if there is a loss 
of membrane integrity. Then, PI positive cells were scored 
as necrotic.
Measurement of cellular reactive oxygen species 
(ROS) production
Three days after lipofection with SG, IFNβ, or βgal 
alone or co-delivered with BLM, cells were detached, 
washed with PBS and incubated with 0.5 µM H2DCF-
DA (Invitrogen) in PBS [7]. After 20 min, normal 
culture conditions were re-established and the cellular 
fluorescence intensity was analyzed by flow cytometry. 
The final data were analyzed using the Flowing software 
(2.5.1, Finland) and the medium intensity of fluorescence 
was calculated (Geometric Mean: Gm).
Determination of size and granularity or internal 
complexity of melanoma cells
Cell size and complexity of control untreated cells 
were analyzed by physical parameters of flow cytometry. 
Forward scatter intensity mainly correlates with cell area 
or size, and side scatter is a measure of the cell refractive 
index that depends on the cell granularity or internal 
complexity.
Colony formation assay
Surviving cells after 3 days of BLM-gene treatments 
were trypsinized up to single cells. Monodispersed cells 
were seeded at low density and incubated at 37oC with 
complete medium until colonies were visible. To generate 
a similar number of colonies, it was necessary to seed 
different number of surviving cells: 500 (Rn), 1500 (Dc, 
Bsk) and 2500 (Rk) cells in a 6-well plate. Medium was 
changed once a week. After 7-10 days of culture, plates 
were washed, fixed with ethanol:acetic acid (3:1, v/v), and 
stained with crystal violet. The number of colonies was 
counted under an inverted microscope. The clonogenic 
capacity was defined as the percentage of seeded cells able 
to grow as colonies of more than 10 cells. 
Cloning efficiency in soft agar
Dispersed cells were resuspended in 0.25% agar in 
culture medium at 1x104 cells/ml and layered on top of 
0.5% agar in culture medium. Three weeks after initiating 
cultures, colonies were counted.
Melanosphere formation assay
Surviving cells after 3 days of BLM-gene treatments 
were trypsinized up to single cells and plated onto 12-well 
low attachment suspension culture plates (Greiner Bio-
One) at a density of 2000 - 2500 viable cells/ml. Cells were 
grown in 1 ml serum-free media, supplemented with B27 
(Gemini Bioproducts), and 20 ng/ml EGF. Melanospheres 
were counted after 6-8 days in culture. The melanosphere 
forming capacity was defined as the percentage of cells 
able of clonal proliferation as melanospheres with more 
than 8 cells.
Statistics
Results were expressed as mean ± standard 
error of the mean (s.e.m.) (n: number of experiments 
corresponding to independent assays). Differences 
between groups were analyzed using unpaired Student’s 
t-test (if two groups), one-way ANOVA followed by 
Tukey’s test (if more than two groups) or two-way 
ANOVA followed by Bonferroni test (if two nominal 
variables). Correlations were determined by Pearson test 
with GraphPad Prism program (GraphPad Software Inc.).
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